QCM
STOK icon

Quantinno Capital Management’s Stoke Therapeutics STOK Stock Holding History

Quantinno Capital Management’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
49,928
+40,155
+411% +$1.29M ﹤0.01% 2145
2026
Q1 		$318K Sell
9,773
-1,315
-12% -$43.1K ﹤0.01% 3004
2025
Q4 		$352K Buy
+11,088
New +$333K ﹤0.01% 2726

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantinno Capital Management's STOK Position: Q2 2026 in Review

Quantinno Capital Management increased its Stoke Therapeutics (STOK) stake by 411% in Q2 2026, buying an estimated $1.29M and bringing the position to 49,928 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

Quantinno Capital Management first reported a position in STOK in Q4 2025 and has held it in 3 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Quantinno Capital Management held 49,928 shares of Stoke Therapeutics worth $1.63M as of Q2 2026.
  • Quantinno Capital Management bought 40,155 Stoke Therapeutics shares in Q2 2026, an estimated $1.29M.
  • Stoke Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2145 holding.
  • Quantinno Capital Management first reported a position in Stoke Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.